Cannabis-induced psychotic disorders are of great clinical and prognostic importance.
Farrowing duration is rather long in sows most likely due to selection for large litters, and we hypothesized that prolonged farrowings would compromise sow energy status during farrowing and in turn the farrowing process. Two studies were performed as follows: 1) to evaluate whether sow energy status during farrowing compromise the farrowing kinetics (FK, i.e., farrowing duration and birth intervals) and 2) to study the underlying mechanisms potentially affecting stillbirth rate and farrowing assistance. In study-1, parameters affecting FK were characterized based on data from a total of 166 farrowings from 7 feeding trials focused on sow colostrum production. The data were screened for associations with FK using the CORR procedure of SAS. Traits that were correlated with the FK at P < 0.05 were included in a multivariate regression model. Time since last meal until the onset of farrowing greatly affected the farrowing duration (r = 0.76; n = 166; P < 0.001) and a broken-line model was fitted to describe that relationship. According to the model, farrowing duration was constant (3.8 ± 1.5 h) if the farrowing started before the breakpoint (3.13 ± 0.34 h after the last meal), whereas farrowing duration increased to 9.3 h if the farrowing started 8 h after the last meal. Subsequently, sows were divided into 3 categories based on that trait (≤3, 3 to 6, and >6 h) to evaluate the impact on birth intervals, farrowing assistance, and stillbirth rate. Birth intervals (P < 0.001), odds for farrowing assistance (P < 0.001), and odds for stillbirth (P = 0.02) were low, intermediate, and high when time since last meal was ≤3, 3 to 6, and >6 h, respectively. In study-2, blood samples were collected once or twice each week in late gestation and each hour during farrowing to measure arterial concentrations and uterine extractions of plasma metabolites. Time since last meal was strongly negatively correlated with arterial glucose 1 h after the onset of farrowing (r= -0.96; n = 9; P < 0.001). Glucose appeared to be the key energy metabolite for oxidative metabolism of gravid uterus. In conclusion, the present study strongly suggests that a substantial proportion of sows suffer from low-energy status at the onset farrowing and that this negatively affects the farrowing process. Transferring this knowledge into practice, the results suggest that sows should be fed at least 3 daily meals in late gestation.
Linkage studies suggest that chromosome 22q12-13 may contain one or more shared susceptibility genes for schizophrenia (SZ) and bipolar affective disorder (BPD). In a Faeroese sample, we previously reported association between microsatellite markers located at 22q13.31-qtel and both disorders. The present study reports an association analysis across five genes (including 14 single nucleotide and two microsatellite polymorphisms) in this interval using a case-control sample of 162 BPD, 103 SZ patients and 200 controls. The bromodomain-containing 1 gene (BRD1), which encodes a putative regulator of transcription showed association with both disorders with minimal P-values of 0.0046 and 0.00001 for single marker and overall haplotype analysis, respectively. A specific BRD1 2-marker 'risk' haplotype showed a frequency of B10% in the combined case group versus B1% in controls (P-value 2.8 Â 10 À7 ). Expression analysis of BRD1 mRNA revealed widespread expression in mammalian brain tissue, which was substantiated by immunohistochemical detection of BRD1 protein in the nucleus, perikaryal cytosol and proximal dendrites of the neurons in the adult rat, rabbit and human CNS. Quantitative mRNA analysis in developing fetal pig brain revealed spatiotemporal differences with high expression at early embryonic stages, with intense nuclear and cytosolar immunohistochemical staining of the neuroepithelial layer and early neuroblasts, whilst more mature neurons at later embryonic stages had less nuclear staining. The results implicate BRD1 with SZ and BPD susceptibility and provide evidence that suggests a role for BRD1 in neurodevelopment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.